An IL6-STAT3 loop mediates resistance to PI3K inhibitors by inducing epithelial–mesenchymal transition and cancer stem cell expansion in human breast cancer cells

Prospective identification of tumorigenic breast cancer cells

Muhammad Al‐Hajj, Max S. Wicha, Adalberto Benito‐Hernández et al. · Proceedings of the National Academy of Sciences · 2003 · 10.4K citations · Full text

Medicine, Cell Biology, Oncology +11

Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy

X. Li, Michael T. Lewis, Jian Huang et al. · JNCI Journal of the National Cancer Institute · 2008 · 1.8K citations · Full text

Medicine, Cancer Biology, Cell Biology +17

An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Lauren A. Byers, Lixia Diao, Jing Wang et al. · Clinical Cancer Research · 2012 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +17

Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells

Nicholas J. Sullivan, A. Kate Sasser, Amy Axel et al. · Oncogene · 2009 · 755 citations

Medicine, Cell Biology, Oncology +16

Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance

Jiangbing Zhou, Julia Wulfkuhle, Hao Zhang et al. · Proceedings of the National Academy of Sciences · 2007 · 702 citations · Full text

Medicine, Cell Biology, Oncology +17